Food and Drug Administration Commissioner Robert Califf is disputing a federal payment database that shows he received a financial benefit from a major drugmaker while on a trip last year.

According to agency records, Califf received $363 last year from pharma giant GlaxoSmithKline for lodging and food expenses, a benefit that could be a violation of agency policy. Those records show the benefit was received before Califf became the commissioner, but while he was an employee of the FDA.